These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 36124026)

  • 1. lncRNAs: Key Regulators of Signaling Pathways in Tumor Glycolysis.
    Wen L; Tan C; Ma S; Li X
    Dis Markers; 2022; 2022():2267963. PubMed ID: 36124026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of lncRNAs in the regulation of aerobic glycolysis in hepatocellular carcinoma: Main functions, regulatory mechanisms and potential therapeutic implications (Review).
    Huang Q; Liang Z; Huang Q; Li X; Xia J; Huang L; Huang LB; Ou C
    Oncol Rep; 2024 Jun; 51(6):. PubMed ID: 38666534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of long non-coding RNAs in glucose metabolism in cancer.
    Fan C; Tang Y; Wang J; Xiong F; Guo C; Wang Y; Zhang S; Gong Z; Wei F; Yang L; He Y; Zhou M; Li X; Li G; Xiong W; Zeng Z
    Mol Cancer; 2017 Jul; 16(1):130. PubMed ID: 28738810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of aerobic glycolysis by long non-coding RNAs in cancer.
    Kong XZ; Hu SS; Sun Z; Zuo LH; Kang J; Zhu ZF; Tian X; Zhang XJ
    Biochem Biophys Res Commun; 2016 Oct; 479(1):28-32. PubMed ID: 27596968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Research progress on the interaction between long non‑coding RNAs and RNA‑binding proteins to influence the reprogramming of tumor glucose metabolism (Review).
    Wu W; Wen K
    Oncol Rep; 2022 Sep; 48(3):. PubMed ID: 35856447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA UCA1 promotes glycolysis by upregulating hexokinase 2 through the mTOR-STAT3/microRNA143 pathway.
    Li Z; Li X; Wu S; Xue M; Chen W
    Cancer Sci; 2014 Aug; 105(8):951-5. PubMed ID: 24890811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coding RNAs in the reprogramming of glucose metabolism in cancer.
    Shankaraiah RC; Veronese A; Sabbioni S; Negrini M
    Cancer Lett; 2018 Apr; 419():167-174. PubMed ID: 29366802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lncRNA MALAT1, acting through HIF-1α stabilization, enhances arsenite-induced glycolysis in human hepatic L-02 cells.
    Luo F; Liu X; Ling M; Lu L; Shi L; Lu X; Li J; Zhang A; Liu Q
    Biochim Biophys Acta; 2016 Sep; 1862(9):1685-95. PubMed ID: 27287256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Warburg effect: essential part of metabolic reprogramming and central contributor to cancer progression.
    Vaupel P; Schmidberger H; Mayer A
    Int J Radiat Biol; 2019 Jul; 95(7):912-919. PubMed ID: 30822194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Warburg meets non-coding RNAs: the emerging role of ncRNA in regulating the glucose metabolism of cancer cells.
    Yu C; Xue J; Zhu W; Jiao Y; Zhang S; Cao J
    Tumour Biol; 2015 Jan; 36(1):81-94. PubMed ID: 25431262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycolysis-associated lncRNAs in cancer energy metabolism and immune microenvironment: a magic key.
    Zhang X; Zhang Y; Liu Q; Zeng A; Song L
    Front Immunol; 2024; 15():1456636. PubMed ID: 39346921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-coding RNAs: Key regulators of aerobic glycolysis in breast cancer.
    Xia M; Feng S; Chen Z; Wen G; Zu X; Zhong J
    Life Sci; 2020 Jun; 250():117579. PubMed ID: 32209425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crosstalk of lncRNA and Cellular Metabolism and Their Regulatory Mechanism in Cancer.
    Lin YH
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNAs: Key regulators involved in metabolic reprogramming in cancer (Review).
    Liu C; Li H; Chu F; Zhou X; Xie R; Wei Q; Yang S; Li T; Liang S; Lü M
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Digging deeper through glucose metabolism and its regulators in cancer and metastasis.
    Ghanavat M; Shahrouzian M; Deris Zayeri Z; Banihashemi S; Kazemi SM; Saki N
    Life Sci; 2021 Jan; 264():118603. PubMed ID: 33091446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of lncRNA-UCA1 suppresses pituitary cancer cell growth and prolactin (PRL) secretion via attenuating glycolysis pathway.
    Liu G; Wang L; Li Y
    In Vitro Cell Dev Biol Anim; 2020 Sep; 56(8):642-649. PubMed ID: 32909148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory Mechanisms of LncRNAs in Cancer Glycolysis: Facts and Perspectives.
    Huang P; Zhu S; Liang X; Zhang Q; Luo X; Liu C; Song L
    Cancer Manag Res; 2021; 13():5317-5336. PubMed ID: 34262341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis identifies a novel lncRNA prognostic signature associated with aerobic glycolysis and hub pathways in breast cancer.
    Li Z; Zheng J; Feng Y; Li Y; Liang Y; Liu Y; Wang X; Yang Q
    Cancer Med; 2021 Nov; 10(21):7877-7892. PubMed ID: 34581026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton export upregulates aerobic glycolysis.
    Russell S; Xu L; Kam Y; Abrahams D; Ordway B; Lopez AS; Bui MM; Johnson J; Epstein T; Ruiz E; Lloyd MC; Swietach P; Verduzco D; Wojtkowiak J; Gillies RJ
    BMC Biol; 2022 Jul; 20(1):163. PubMed ID: 35840963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cancer cell signaling by long noncoding RNAs.
    Mirhosseini SA; Sarfi M; Samavarchi Tehrani S; Mirazakhani M; Maniati M; Amani J
    J Cell Biochem; 2019 Aug; 120(8):12224-12246. PubMed ID: 31069841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.